In this study, we analyzed the expression level of SOX4 and its association with GBM patient survival using the data from TCGA (Additional file 2: Table S2) including data from all three analytical platforms (U133 microarray, Agilent and RNA Seq V2 RSEM). The gene discussed is SOX4; the disease is glioblastoma.